Concepedia

Hiroko Omoya

HO

Statistics

Publications

5

Citations

151

H-Index

5

Active since

1990

Affiliations

Sumitomo Dainippon Pharma (Japan)(Current)

Hiroko Omoya is an author at Sumitomo Dainippon Pharma (Japan) specializing in molecular pharmacology, pharmacotherapy, and medicine.

Top concepts

Publications per year

1990–1993

5

Publications

5

AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.

Naoyuki Yoshida, Hiroko Omoya, Masahiko Oka et al. · PubMed · 1990 · 52 citations

, , +19

Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.

Naoyuki Yoshida, Hiroko Omoya, Suguru Kato et al. · PubMed · 1993 · 44 citations

, , +16

Comparison of gastrokinetic effects of AS-4370, cisapride and BRL24924

Tadahiko Karasawa, Naoyuki Yoshida, K. Furukawa et al. · European Journal of Pharmacology · 1990 · 24 citations

, , +6

DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.

Nagahide Yoshida, Hiroko Omoya, Takao Ito · Journal of Pharmacology and Experimental Therapeutics · 1992 · 19 citations

5-HT3 receptor antagonist effects of DAT-582, (R) enantiomer of AS-5370

Naoyuki Yoshida, Hiroko Omoya, Shiro Kato et al. · European Journal of Pharmacology · 1992 · 12 citations

, , +7

1–5 of 5